News

Investing in a basket of growth stocks in your younger years can yield significant results by retirement age.

Even if you're starting from zero, a reasonably diversified portfolio could get you there sooner than you think.

HSBC (NYSE:HSBC) reported third-quarter revenue growth of 5% and a 10% increase in profit before tax excluding notable items, while reaffirming its full-year guidance and announcing an up to $1 billion share buyback. Group CFO Pam Kaur said revenue rose to $18.7 billion in the quarter, while profit

The new ETF offers a sense of safety, but that doesn't mean it's a good purchase.

This equipment vendor is on sale once again.

Vanguard's 0.09% expense ratio and broader 103-stock portfolio delivered slightly higher five-year returns, while iShares offers more concentration and a higher 2.4% dividend yield.

Two real estate ETFs offer exposure to some of the industry's largest property owners, but differences in dividends, fees, and diversification could make one a better choice for long-term investors.

This international dividend ETF is an ideal complement to an S&P 500 index fund.

The Schwab U.S. Dividend Equity ETF has soared past the S&P 500 this year.

Brazil stocks tumbled on election news, though not much is changing after the result.

The Oracle of Omaha doesn't think most investors should pick individual stocks.

The bursting of an AI bubble would sink the S&P 500, but don't count on it happening just yet.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Arrivals to and departures from the iShares Bitcoin Trust ETF and other spot Bitcoin ETFs are interesting, but not necessarily instructive.

Astrazeneca (NYSE:AZN) highlighted new clinical data across bladder, lung and gastric cancers at its ESMO 2026 investor event, including four presidential presentations that executives said support the company’s oncology growth strategy. Dave Fredrickson, executive vice president of the company’s o

The fund beat the index the year after four of its five lagging years since 2005. Is this a reason to buy today?

Major cryptocurrencies weakened amid broader risk aversion as traders await the Fed decision.

FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.

The fee gap between these two funds is one of the widest in the ETF market. Whether EEM’s growth potential is worth it is the real question.

The S&P 500 is at around record levels, with a lot of exposure to tech.

The pro-capitalism Presidential candidate expected to win Sunday’s election was defeated by the incumbent, potentially setting the stage for economy-undermining turmoil.

IHE has outperformed recently by concentrating in U.S. drugmakers. PPH offers global reach and a higher dividend for investors willing to trade some of that momentum for income.

Which of these diversified ETFs has more upside potential?

XLV concentrates on 61 large-cap S&P 500 names, while FHLC casts a wider net with 365 holdings across mid and small caps. Both charge 0.08% annually.

While chip stocks slide, cybersecurity and software names like HACK, IGV, Microsoft, CrowdStrike, and Palantir hold near highs, suggesting a rotation within tech rather than a broad exit.